StockData
CalciMedica, Inc. logo

CalciMedica, Inc. (CALC) stock

CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.22+0.03 (+2.52%)

Close on Nov 17, 2026Market cap $41.65MP/E –Yield –

CalciMedica ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

CalciMedica's ebitda for the twelve months ending Dec 31, 2023 was -$38.02M. For fiscal 2023 it was -$38.02M.

Annual ebitda

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$38.02M–
FY2022Dec 31, 2022-$14.14M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023-$4.30M–
Q3 FY2023Sep 30, 2023-$4.82M–
Q2 FY2023Jun 30, 2023-$6.57M–
Q1 FY2023Mar 31, 2023-$22.33M–
Q2 FY2022Jun 30, 2022-$3.58M–
Q1 FY2022Mar 31, 2022-$4.20M–

More CalciMedica figures

See a number that looks wrong?